Nanomedicine combats drug resistance in lung cancer

X Zheng, X Song, G Zhu, D Pan, H Li, J Hu… - Advanced …, 2024 - Wiley Online Library
Lung cancer is the second most prevalent cancer and the leading cause of cancer‐related
death worldwide. Surgery, chemotherapy, molecular targeted therapy, immunotherapy, and …

[HTML][HTML] Micro and nano-carriers-based pulmonary drug delivery system: Their current updates, challenges, and limitations–A review

M Kumar, AR Hilles, SH Almurisi, A Bhatia, S Mahmood - JCIS Open, 2023 - Elsevier
The lung is an attractive target for drug delivery because of the ease of non-invasive
administration via inhalation, bypassing metabolism in the liver, direct delivery to the …

A critical review on developments in drying technologies for enhanced stability and bioavailability of pharmaceuticals

K Jadhav, E Kole, R Singh, SK Rout, RK Verma… - Drying …, 2024 - Taylor & Francis
Drying is a widely adopted unit operation that enhances the stability of pharmaceuticals.
Conventionally, freeze-drying has been chosen, as evidenced by the numerous freeze-dried …

Clofazimine nanoclusters show high efficacy in experimental TB with amelioration in paradoxical lung inflammation

K Jadhav, A Jhilta, R Singh, E Ray, N Sharma… - Biomaterials …, 2023 - Elsevier
The rise of tuberculosis (TB) superbugs has impeded efforts to control this infectious ailment,
and new treatment options are few. Paradoxical Inflammation (PI) is another major problem …

[HTML][HTML] Advancements in chitosan-based nanoparticles for pulmonary drug delivery

TM Zacaron, MLS Silva, MP Costa, DM Silva, AC Silva… - Polymers, 2023 - mdpi.com
The evolution of respiratory diseases represents a considerable public health challenge, as
they are among the leading causes of death worldwide. In this sense, in addition to the high …

Effective cerebral tuberculosis treatment via nose-to-brain transport of anti-TB drugs using mucoadhesive nano-aggregates

K Jadhav, A Jhilta, R Singh, E Ray, V Kumar, AB Yadav… - Nanoscale, 2024 - pubs.rsc.org
Central nervous system tuberculosis (CNS-TB) is a severe form of extra-pulmonary
tuberculosis with high mortality and morbidity rates. The standard treatment regimen for CNS …

Trans-nasal brain delivery of anti-TB drugs by methyl-β-cyclodextrin microparticles show efficient mycobacterial clearance from central nervous system

K Jadhav, A Jhilta, R Singh, S Sharma, S Negi… - Journal of Controlled …, 2025 - Elsevier
Central nervous system tuberculosis (CNS-TB) is the most severe extra-pulmonary
manifestation of tuberculosis (TB), facing significant challenges due to the limited …

Breaking the Cycle: Matrix Metalloproteinase Inhibitors as an Alternative Approach in Managing Tuberculosis Pathogenesis and Progression

A Jhilta, K Jadhav, R Singh, E Ray, A Kumar… - ACS Infectious …, 2024 - ACS Publications
Mycobacterium tuberculosis (Mtb) has long posed a significant challenge to global public
health, resulting in approximately 1.6 million deaths annually. Pulmonary tuberculosis (TB) …

Inhalable chitosan-coated nano-assemblies potentiate niclosamide for targeted abrogation of non-small-cell lung cancer through dual modulation of autophagy and …

E Ray, K Jadhav, M Kadian, G Sharma… - International Journal of …, 2024 - Elsevier
Lung carcinoma, particularly non-small-cell lung cancer (NSCLC), accounts for a significant
portion of cancer-related deaths, with a fatality rate of approximately 19%. Niclosamide …

Targeted delivery of the metastasis-specific tumour homing TMTP1 peptide to non-small-cell lung cancer (NSCLC) using inhalable hybrid nano-assemblies

E Ray, K Jadhav, M Kadian, G Sharma… - Journal of Materials …, 2024 - pubs.rsc.org
Lung cancer is one of the most fatal malignancies, with the highest death rate (∼ 19%), and
the NSCLC type accounts for∼ 85% of lung cancers. In the search for new treatments …